Minimizing the side effects and risk of skin cancer
The digital phototherapy device skintrek® PT5 is a modern, medical device created to treat skin diseases like Psoriasis, Vitiligo and eczema (i.e. neurodermatitis). In the process the UV-exposure of skin lesions is performed by about 800.000 digitized Pixel rays with high contour precision and in a localized selective manner. This kind of phototherapy is called digital phototherapy. It vastly minimizes the risk of skin cancer caused by the treatment, since no healthy skin is exposed by UV-rays. Furthermore side effects, like ageing of the skin and pigmentation of healthy skin, which are quite common in conventional part or whole body phototherapy, are eliminated.
Faster therapy for Psoriasis
Since only diseased areas of skin are exposed during the therapy for Psoriasis, it is possible to apply higher doses without the risk of sunburn on healthy skin. New medical studies shown that in this way fewer sessions are necessary to successfully treat the affected areas.
Depending on the pattern of disease and the desired therapy different UV-spectrums are used in the digital phototherapy. To meet this need the UV-spectrum of the skintrek® PT5 can be easily switched from UVA (320 nm – 400 nm) to UVB (300 nm – 320 nm).
Automatic detection of lesions
The patented skintrek® technology and an integrated camera in the exposure head allow it to automatically detect diseased lesions on the patient’s skin. The doctor can also manage this process manually to either define lesions that are hard to detect by the system, delete mistakenly detected skin areas or correct the margin areas of lesions. This process is handled easily and quickly by a graphic interface on the skintrek®PT5’s touchscreen.
Automatic motion tracking
The patient does not have to be immobilized during the treatment because small movements will be detected and tracked. In this way healthy areas of skin on the edges of lesions are only slightly affected, even when the patient moves because the motion tracking happens within fractions of a second. If a patient completely leaves his “defined movement space” the UV-therapy will automatically stop.
Constant UV-Dose and adjustable profile of dosage
The therapeutic dose of rays can be set individually at the phototherapy device skintrek® PT5. During the phototherapy the power of the device is automatically regulated and the applied dose is precisely calculated. When reaching the prescribed dose the exposure will automatically switch off. To make sure the predefined dose is applied to every affected skin area the skintrek® PT5 also checks the topography of the skin surface. This way, skin areas that lie at an angle to the incidence angle of the rays are also treated with the exact dosage. Furthermore, the doctor can create profiles of dosage, that allow it to apply a continuously decreasing UV-dose at the edge of the lesions.
4-dimensional movement of the exposure head
The exposure head of the skintrek® PT5 is movable in 4 dimensions to make every part of the patient’s body easy to treat without making the patient repeatedly change his/her position. The positioning is carried out with modern and high-precision stepping motors.
Dimensions (LxWxH) : 3.320 mm x 900 mm x 1.830 mm (130” x 35” x 72”)
Power : 230 V~, 50 Hz , max. 1.200 W
Weight : approx. 380 kg (837 lbs.)
UV Spectrum (choice) : UVA, 320 nm – 400 nm ; UVB, 300 nm – 320 nm
The developing of the phototherapy device skintrek® PT5 is supported by the Federal Ministry of Economics and Technology (BMWi) within the support program “Central innovation program for small and medium-sized enterprises.”
Skintrek PT5 Brochure (386.9 kB)